AVE 33.3% 0.2¢ avecho biotechnology limited

we made the smh..., page-115

  1. 5,322 Posts.
    So if the Bell Potter figure is in the ballpark. POH has $3-5 Mill to claw back from those behind the missing monies and or Auditors. What is chance Auditor Insurance will cover this? I wonder as to how Auditors could have missed so much cash missappropriated in such a small company. So iI find myself on one hand gobbsmaked by the amount of funds missing- but optimistic some if not all can be recovered leaving POH with a greatly enhanced cash position. . No wonder Esra has been stood aside. And finally - Does this impact the entire sector? Of course it does not. What about POH? Commercial and clinical progress will nulify this very unfortunate situation. POHs top 20 are onboard and resolute to see thus through. POH is still a Buy for me
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(33.3%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.3¢ 0.3¢ 0.2¢ $11.50K 4.335M

Buyers (Bids)

No. Vol. Price($)
63 101422109 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 20872825 7
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.